Hotchkis & Wiley Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $8.48M | Sell |
|
|||||
|
2023
Q1 | $6.91M | Buy |
|
|||||
|
2022
Q4 | $8.11M | Buy |
|
|||||
|
2022
Q3 | $7.15M | Buy |
|
|||||
|
2022
Q2 | $7.97M | Buy |
|
|||||
|
2022
Q1 | $8.3M | Buy |
|
|||||
|
2021
Q4 | $7.87M | Buy |
|
|||||
|
2021
Q3 | $8.61M | Buy |
|
|||||
|
2021
Q2 | $9.2M | Buy |
|
|||||
|
2021
Q1 | $8.08M | Buy |
|
|||||
|
2020
Q4 | $7.42M | Buy |
|
|||||
|
2020
Q3 | $4.62M | Buy |
|
|||||
|
2020
Q2 | $4.47M | Sell |
|
|||||
|
2020
Q1 | $4.38M | Sell |
|
|||||
|
2019
Q4 | $6.7M | Buy |
|
|||||
|
2019
Q3 | $5.05M | Buy |
|
|||||
|
2019
Q2 | $5.46M | Buy |
|
|||||
|
2019
Q1 | $6.2M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $22M | Buy |
|
|||||
|
2016
Q1 | $21.3M | Buy |
|
|||||
|
2015
Q4 | $21.1M | Buy |
|
|||||
|
2015
Q3 | $18.7M | Sell |
|
|||||
|
2015
Q2 | $20M | Sell |
|
|||||
|
2015
Q1 | $29.2M | Sell |
|
|||||
|
2014
Q4 | $31.3M | Sell |
|
|||||
|
2014
Q3 | $42.3M | Sell |
|
|||||
|
2014
Q2 | $71.7M | Buy |
|
|||||
|
2014
Q1 | $50.5M | Sell |
|
|||||
|
2013
Q4 | $52.4M | Buy |
|
|||||
|
2013
Q3 | $33.3M | Buy |
|